Author Archives: Jan Paschal

Caris Life Sciences (CAI) gave IPO investors something to celebrate in its NASDAQ debut. Shares of Caris Life Sciences (CAI) shot up  28.6 percent to open at $27.00 – up $6.00 from the IPO price – on Wednesday, June 18, 2025 – and ended their first day of NASDAQ trading at $28.00 – up $7.00 for a gain of […]

IPO investors in Slide Insurance Holdings (SLDE) basked in some Florida sunshine today. Shares of Slide, a Tampa, Florida-based coastal home and condo insurer, opened at $21.00 –  up $4.00 from their IPO price – at 12:01 p.m. EDT today – Wednesday, June 18, 2025 – on NASDAQ volume of about 2.42 million shares. Slide’s […]

Souffle, anyone?  Enigmatig (EGG), a Hong Kong cross-border licensing consultant, popped up to $13.34 – up $8.34 from the stock’s $5.00 IPO price – to score a moonshot in its NYSE – American Exchange (NYSE – AmEx) debut today (Wednesday, June 18, 2025). Enigmatig’s stock touched its intraday high at around 10:47 a.m. EDT today […]

  Wall Street’s SPAC IPO machine priced two more big blank check deals on Tuesday night, June 17, 2025, and raised a total of $395 million. Both SPACS were set to make their debuts today – Wednesday, June 18, 2025,  on NASDAQ. Both SPACs were priced in line with the terms in their prospectuses: – Pioneer […]

Caris Life Sciences (CAI) priced its IPO at $21.00 – $1.00 above the top of its recently increased range – and sold 23.53 million shares – the number of shares in the prospectus – to raise $494.12 million on Tuesday night, June 17, 2025. The price range was $19.00 to $20.00 – increased on Monday, June […]

Slide Insurance Holdings Inc. (SLDE) increased its IPO’s size by 20 percent to 24 million shares and priced the IPO at $17.00 – the high end of its $15.00-to-$17.00 range – to raise $408 million on Tuesday night, June 17, 2025. The Florida home and condo  insurer had a market cap of about $2.19 billion […]

Jyong Biotech Ltd. (MENS), a Taiwan-based biotech developing drugs to treat benign prostate hyperplasia and to prevent prostate cancer, priced its IPO at $7.50 – the low end of its range – and sold 2.7 million shares – the number of shares in the prospectus – to raise $20.0 million on Monday night, June 16, […]

Caris Life Sciences, Inc. (CAI Proposed), an AI TechBio precision medicine pioneer focused on cancer, increased its IPO price range to $19.00 to $20.00 – up from its initial price range of $16.00 to $18.00 – and kept the number of shares at 23.53 million shares – to raise $458.84 million, if priced at $19.50, the […]

Now, Voyager: The IPO market’s rocket launch in June produced a couple of moonshots and a week that gave IPO players something to celebrate. The momentum – and the moment – began to take shape in May with the successful IPOs of eToro (ETOR), MNTN, Inc. (MNTN) and Hinge Health (HNGE). A moonshot occurs when […]

Jefferson Capital, Inc. (JCAP Proposed), a profitable consumer debt purchaser and debt collection company, unveiled its IPO terms – 10.0 million shares at a price range of $15.00 to $17.00 – to raise $160 million, if priced at the $16.00 mid-point, in an S-1/A filing early today, Friday, June 13, 2025. Of the 10 million […]